US Approves Pfizer COVID-19 Vaccine for Children as Young as 12
WHO: Variant circulating in India is of 'global' concern
WHO: Variant circulating in India is of 'global' concern
African officials worry about delays in vaccine deliveries caused by India's crisis
Panel calls for more data before deciding how and whether to resume use of the one-dose shot
South Africa lauds arrival of tens of millions of doses; announces alcohol ban over major holiday weekend
Health Ministry says up to 40 people were testing positive for COVID-19 daily around the site of the weeks-long Mahakumbh that began this month and pe
Survey finds trust in COVID-19 vaccines has risen in nine out of 14 countries covered
FDA could OK Johnson & Johnson vaccine as early as Saturday
Results revealed in first analysis of national COVID-19 vaccination strategy
Scams are on the rise according to European and US government officials who are warning public of fraudsters out for money and personal data
Relief as COVID-19 restrictions eased slightly for Christmas in Sydney as infections increase
Sydney fears Christmas will be cancelled as COVID-19 cluster grows and travel restrictions imposed by other Australian states and territories
Pork-derived gelatin has been widely used as a stabilizer in vaccines
Sites scheduled to start giving shots as soon as Monday
Inoculations can't come soon enough in nations breaking daily COVID-19 records for cases and deaths
US Food and Drug Administration widely expected to authorize emergency use after special panel votes to recommend approval//
France breaks 2 million total coronavirus cases threshold, first nation in Europe to reach milestone
In futures trading, all three major US indices are trending negatively
US indices are mixed in futures trading, with the Dow and the S&P 500 trading negatively, while the Nasdaq is slightly higher
Despite the uncertainty surrounding the political stalemate in Washington, all three major US indices are trending positively in futures trading
Government lowered its 2020 growth target this month from 2.5% to 2%
Scientists voice increasing confidence about development of vaccines, but warn governments aren't spending enough to avoid shortfalls in doses
Clinical success isn't enough, experts say